Delivery Order SPE2DB22D6029-SPE2DB25FLVEW
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNARIS 50 MCG NASAL SPRAY 12.5GM, a pharmaceutical product. The contract has a firm fixed price, no set-aside designation, and a ceiling value of $1,053.77. The period of performance extends through May 16, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
The Defense Logistics Agency awarded a $1,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561751439 OMNARIS 50 MCG nasal spray. As the prime contractor, Amerisourcebergen will deliver 12.5 grams of the nasal spray medication to its place of performance in Conshohocken, Pennsylvania by August 10, 2023 to fulfill DLA's requirements. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform under this contract without a set-aside designation. As a...
This federal contract award, valued at $1,576.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Omnaris 50 MCG Nasal Spray 12.5GM, a pharmaceutical product, with a completion date of May 10, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,564.77 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Omnaris 50 mcg nasal spray. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania headquarters, with all supplies delivered by October 30, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite delivery contract held by...
This is a $1,322.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QNASL 80 MCG nasal spray. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.56, is for the delivery of QNASL 80 MCG NASAL SPRAY 10.6GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a $1,434.44 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dristan 0.05% nasal spray. The contract has a period of performance through September 6, 2024. AmerisourceBergen, as the prime contractor, will provide these pharmaceuticals to support military treatment facilities and other federal healthcare programs. This delivery order is part of a larger Indefinite Delivery...
This federal contract award, valued at $18,911.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for the delivery of QNASL 80 MCG NASAL SPRAY 10.6GM, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the purchase of NARCAN 4 MG NASAL SPRAY 2S. The $7,350.25 firm fixed price contract has a completion date of January 31, 2023 and is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,325.92 contract is for the supply of QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product. The award has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...